Phase II open-label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid-Lung-A
- Issued Date
- 2021
- Type
- Article
- Publisher
- Thoracic Cancer
- Language
- 영어
- ISSN
- 1759-7706
- Citation Volume
- 12
- Citation Number
- 4
- Citation Start Page
- 444
- Citation End Page
- 452
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.